Global Drug Discovery Bayer Schering Pharma, Muellerstraße 178, 13342 Berlin, Germany.
Drug Discov Today. 2011 Apr;16(7-8):288-92. doi: 10.1016/j.drudis.2010.11.013. Epub 2010 Dec 1.
Collaborations between industry and academia are steadily gaining importance. To combine expertises Bayer Healthcare has set up a novel open innovation approach called Grants4Targets. Ideas on novel drug targets can easily be submitted to http://www.grants4targets.com. After a review process, grants are provided to perform focused experiments to further validate the proposed targets. In addition to financial support specific know-how on target validation and drug discovery is provided. Experienced scientists are nominated as project partners and, depending on the project, tools or specific models are provided. Around 280 applications have been received and 41 projects granted. According to our experience, this type of bridging fund combined with joint efforts provides a valuable tool to foster drug discovery collaborations.
工业界和学术界之间的合作正变得越来越重要。为了结合专业知识，拜耳医疗保健公司建立了一种新的开放式创新方法，称为 Grants4Targets。关于新药物靶点的想法可以很容易地提交到 http://www.grants4targets.com。经过审查过程，将提供资助金来进行重点实验，以进一步验证所提出的靶点。除了提供资金支持外，还提供关于靶点验证和药物发现的特定专业知识。经验丰富的科学家被提名担任项目合作伙伴，并且根据项目的不同，提供工具或特定模型。已经收到了大约 280 份申请，并批准了 41 个项目。根据我们的经验，这种类型的桥梁基金与联合努力相结合，为促进药物发现合作提供了一个有价值的工具。
